# Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A.

> **NCT01494779** · PHASE1 · UNKNOWN · sponsor: **Azidus Brasil** · enrollment: 32 (estimated)

## Conditions studied

- GH Deficiency (GHD)
- Growth Retardation

## Interventions

- **DRUG:** Somatropin
- **DRUG:** Somatropin

## Key facts

- **NCT ID:** NCT01494779
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2013-06
- **Final completion:** 2013-08
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2012-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01494779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01494779, "Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01494779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*